Case activity for Dermavance Pharmaceuticals Inc. vs Medinter Ltd., British Virgin Islands on March 10

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Dermavance Pharmaceuticals Inc. against Medinter Ltd., British Virgin Islands on March 10.

'Complaint Against Medinter, Ltd., British Virgin Islands ( Filing Fee $ 402 Receipt Number 0313-14972690.), Filed By Dermavance Pharmaceuticals, Inc.. (attachments: # 1 Exhibit License Agreement, # 2 Civil Cover Sheet, # 3 Case Management Track Form, # 4 Designation Form)(larosa, Michael)'

'Statement Of Corporate Disclosure By Dermavance Pharmaceuticals, Inc.. (larosa, Michael)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By Dermavance Pharmaceuticals, Inc. *for Pdf See Doc. 2 *(lisad, )'

'Demand For Trial By Jury By Dermavance Pharmaceuticals, Inc.. (lisad, )'

'Notice Of Appearance By Ryan Thomas Becker On Behalf Of Medinter, Ltd., British Virgin Islands (becker, Ryan)'

'Waiver Of Service Returned Executed By Medinter, Ltd., British Virgin Islands. Medinter, Ltd., British Virgin Islands Waiver Sent On 3/10/2021, Answer Due 6/8/2021. (becker, Ryan)'

Case number 2:21-cv-01144-CDJ was filed in the U.S. District Court for the Eastern District of Pennsylvania on March 10.